
Reset all filters
01 1Raks Pharma
Reset all filters
01 1APREMILAST
Reset all filters
01 1India
Reset all filters
01 1Active
Reset all filters
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-01
Pay. Date : 2016-12-27
DMF Number : 31180
Submission : 2016-12-29
Status : Active
Type : II
20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is APREMILAST, with a corresponding US DMF Number 31180.
Remarkably, this DMF maintains an Active status since its submission on December 29, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 01, 2017, and payment made on December 27, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II